...
首页> 外文期刊>Journal of inherited metabolic disease >Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis.
【24h】

Inefficient cleavage of palmitoyl-protein thioesterase (PPT) substrates by aminothiols: implications for treatment of infantile neuronal ceroid lipofuscinosis.

机译:氨基硫醇对棕榈酰蛋白硫酯酶(PPT)底物的低效切割:对婴儿神经元类固醇脂褐藻病的治疗意义。

获取原文
获取原文并翻译 | 示例

摘要

Infantile neuronal ceroid lipofuscinosis (INCL, also known as infantile Batten disease) is a devastating neurodegenerative disorder caused by deficiency in the lysosomal enzyme palmitoyl-protein thioesterase (PPT, or CLN1), which functions to remove long-chain fatty acids from cysteine residues in proteins. A previous study suggested that the drug cysteamine, a simple aminothiol used in the treatment of cystinosis, may have utility in the treatment of INCL. In the current study, we compared the catalytic rate constants for the conversion of palmitoyl-CoA (a PPT substrate) and cystine (which accumulates in cystinosis) by cysteamine. We found that while cysteamine can react with palmitoyl-CoA, the rate constant is 10(3)-fold less than the reaction with cystine. Structure-activity studies suggested that it is the thiolate ion that is reactive in the cleavage reaction and that the amino group probably facilitates lysosomal entry. A modest effect of cysteamine (and two related aminothiols, WR 1065 and dimethylaminoethanethiol, DMAET) on PPT substrate accumulation in INCL lymphoblasts was observed. However, at optimum concentration a paradoxical increase in saposin immunoreactivity was seen, indicating possible lysosomal dysfunction. Improvements are needed in the design of small molecules for the treatment of INCL disease.
机译:婴儿神经元类脂褐质病(INCL,也称为婴儿巴顿病)是一种破坏性神经退行性疾病,由溶酶体酶棕榈酰蛋白硫酯酶(PPT或CLN1)缺乏引起,其功能是去除半胱氨酸残基中的长链脂肪酸。蛋白质。先前的研究表明,药物半胱胺(一种用于治疗胱氨酸病的简单氨基硫醇)可能在INCL的治疗中具有实用性。在当前的研究中,我们比较了半胱胺转化为棕榈酰辅酶A(PPT底物)和胱氨酸(在胱氨酸中积累)的催化速率常数。我们发现,虽然半胱胺可以与棕榈酰辅酶A反应,但速率常数比与半胱氨酸的反应少10(3)倍。结构活性研究表明,硫醇根离子在裂解反应中具有反应性,并且氨基可能促进了溶酶体的进入。观察到半胱胺(和两种相关的氨基硫醇,WR 1065和二甲基氨基乙硫醇,DMAET)对INCL淋巴母细胞中PPT底物积累的适度影响。然而,在最佳浓度下,观察到沙波菌素免疫反应性反常增加,表明可能存在溶酶体功能障碍。在治疗INCL疾病的小分子设计中需要改进。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号